Evercore ISI Group Initiates Coverage On Apnimed with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 77.3%

Neg 0% Neu 0% Pos 77.3%

Evercore ISI Group analyst Umer Raffat initiates coverage on Apnimed (NASDAQ:APMD) with a Outperform rating.

Comments

No comments yet. Be the first!